Exosome Diagnostics and Therapeutics Market, Global Outlook and Forecast 2022-2028

March 2022 | 61 pages | ID: EE5E9425DE64EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Exosome Diagnostics and Therapeutics in Global, including the following market information:

Global Exosome Diagnostics and Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Exosome Diagnostics and Therapeutics market was valued at 101.1 million in 2021 and is projected to reach US$ 760.6 million by 2028, at a CAGR of 33.4% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Instrument Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Exosome Diagnostics and Therapeutics include Aethlon Medical(US), Exosome Diagnostics(US), NanoSomix Inc.(US), Thermo Fisher Scientific (US), Malvern Instruments (UK), System Biosciences(US), NX Pharmagen (US), Sistemic Inc(UK) and Capricor Therapeutics (US) and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Exosome Diagnostics and Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Exosome Diagnostics and Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Exosome Diagnostics and Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Instrument
• Reagent
• Software

Global Exosome Diagnostics and Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Exosome Diagnostics and Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Diagnostic
• Therapeutic

Global Exosome Diagnostics and Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Exosome Diagnostics and Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Exosome Diagnostics and Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Exosome Diagnostics and Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Aethlon Medical(US)
• Exosome Diagnostics(US)
• NanoSomix Inc.(US)
• Thermo Fisher Scientific (US)
• Malvern Instruments (UK)
• System Biosciences(US)
• NX Pharmagen (US)
• Sistemic Inc(UK)
• Capricor Therapeutics (US)
• Exiqon A/S (Denmark)

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Exosome Diagnostics and Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Exosome Diagnostics and Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL EXOSOME DIAGNOSTICS AND THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Exosome Diagnostics and Therapeutics Market Size: 2021 VS 2028
2.2 Global Exosome Diagnostics and Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Exosome Diagnostics and Therapeutics Players in Global Market
3.2 Top Global Exosome Diagnostics and Therapeutics Companies Ranked by Revenue
3.3 Global Exosome Diagnostics and Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Exosome Diagnostics and Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Exosome Diagnostics and Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Exosome Diagnostics and Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Exosome Diagnostics and Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Exosome Diagnostics and Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Exosome Diagnostics and Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Instrument
  4.1.3 Reagent
  4.1.4 Software
4.2 By Type - Global Exosome Diagnostics and Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Exosome Diagnostics and Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Exosome Diagnostics and Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Exosome Diagnostics and Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Exosome Diagnostics and Therapeutics Market Size, 2021 & 2028
  5.1.2 Diagnostic
  5.1.3 Therapeutic
5.2 By Application - Global Exosome Diagnostics and Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Exosome Diagnostics and Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Exosome Diagnostics and Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Exosome Diagnostics and Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Exosome Diagnostics and Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Exosome Diagnostics and Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Exosome Diagnostics and Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Exosome Diagnostics and Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Exosome Diagnostics and Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Exosome Diagnostics and Therapeutics Revenue, 2017-2028
  6.3.2 US Exosome Diagnostics and Therapeutics Market Size, 2017-2028
  6.3.3 Canada Exosome Diagnostics and Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Exosome Diagnostics and Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Exosome Diagnostics and Therapeutics Revenue, 2017-2028
  6.4.2 Germany Exosome Diagnostics and Therapeutics Market Size, 2017-2028
  6.4.3 France Exosome Diagnostics and Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Exosome Diagnostics and Therapeutics Market Size, 2017-2028
  6.4.5 Italy Exosome Diagnostics and Therapeutics Market Size, 2017-2028
  6.4.6 Russia Exosome Diagnostics and Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Exosome Diagnostics and Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Exosome Diagnostics and Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Exosome Diagnostics and Therapeutics Revenue, 2017-2028
  6.5.2 China Exosome Diagnostics and Therapeutics Market Size, 2017-2028
  6.5.3 Japan Exosome Diagnostics and Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Exosome Diagnostics and Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Exosome Diagnostics and Therapeutics Market Size, 2017-2028
  6.5.6 India Exosome Diagnostics and Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Exosome Diagnostics and Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Exosome Diagnostics and Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Exosome Diagnostics and Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Exosome Diagnostics and Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Exosome Diagnostics and Therapeutics Market Size, 2017-2028
  6.7.3 Israel Exosome Diagnostics and Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Exosome Diagnostics and Therapeutics Market Size, 2017-2028
  6.7.5 UAE Exosome Diagnostics and Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Aethlon Medical(US)
  7.1.1 Aethlon Medical(US) Corporate Summary
  7.1.2 Aethlon Medical(US) Business Overview
  7.1.3 Aethlon Medical(US) Exosome Diagnostics and Therapeutics Major Product Offerings
  7.1.4 Aethlon Medical(US) Exosome Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Aethlon Medical(US) Key News
7.2 Exosome Diagnostics(US)
  7.2.1 Exosome Diagnostics(US) Corporate Summary
  7.2.2 Exosome Diagnostics(US) Business Overview
  7.2.3 Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Major Product Offerings
  7.2.4 Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Exosome Diagnostics(US) Key News
7.3 NanoSomix Inc.(US)
  7.3.1 NanoSomix Inc.(US) Corporate Summary
  7.3.2 NanoSomix Inc.(US) Business Overview
  7.3.3 NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Major Product Offerings
  7.3.4 NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 NanoSomix Inc.(US) Key News
7.4 Thermo Fisher Scientific (US)
  7.4.1 Thermo Fisher Scientific (US) Corporate Summary
  7.4.2 Thermo Fisher Scientific (US) Business Overview
  7.4.3 Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Major Product Offerings
  7.4.4 Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Thermo Fisher Scientific (US) Key News
7.5 Malvern Instruments (UK)
  7.5.1 Malvern Instruments (UK) Corporate Summary
  7.5.2 Malvern Instruments (UK) Business Overview
  7.5.3 Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Major Product Offerings
  7.5.4 Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Malvern Instruments (UK) Key News
7.6 System Biosciences(US)
  7.6.1 System Biosciences(US) Corporate Summary
  7.6.2 System Biosciences(US) Business Overview
  7.6.3 System Biosciences(US) Exosome Diagnostics and Therapeutics Major Product Offerings
  7.6.4 System Biosciences(US) Exosome Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 System Biosciences(US) Key News
7.7 NX Pharmagen (US)
  7.7.1 NX Pharmagen (US) Corporate Summary
  7.7.2 NX Pharmagen (US) Business Overview
  7.7.3 NX Pharmagen (US) Exosome Diagnostics and Therapeutics Major Product Offerings
  7.7.4 NX Pharmagen (US) Exosome Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 NX Pharmagen (US) Key News
7.8 Sistemic Inc(UK)
  7.8.1 Sistemic Inc(UK) Corporate Summary
  7.8.2 Sistemic Inc(UK) Business Overview
  7.8.3 Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Major Product Offerings
  7.8.4 Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Sistemic Inc(UK) Key News
7.9 Capricor Therapeutics (US)
  7.9.1 Capricor Therapeutics (US) Corporate Summary
  7.9.2 Capricor Therapeutics (US) Business Overview
  7.9.3 Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Major Product Offerings
  7.9.4 Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 Capricor Therapeutics (US) Key News
7.10 Exiqon A/S (Denmark)
  7.10.1 Exiqon A/S (Denmark) Corporate Summary
  7.10.2 Exiqon A/S (Denmark) Business Overview
  7.10.3 Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Major Product Offerings
  7.10.4 Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 Exiqon A/S (Denmark) Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Exosome Diagnostics and Therapeutics Market Opportunities & Trends in Global Market
Table 2. Exosome Diagnostics and Therapeutics Market Drivers in Global Market
Table 3. Exosome Diagnostics and Therapeutics Market Restraints in Global Market
Table 4. Key Players of Exosome Diagnostics and Therapeutics in Global Market
Table 5. Top Exosome Diagnostics and Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Exosome Diagnostics and Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Exosome Diagnostics and Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Exosome Diagnostics and Therapeutics Product Type
Table 9. List of Global Tier 1 Exosome Diagnostics and Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Exosome Diagnostics and Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Exosome Diagnostics and Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Exosome Diagnostics and Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Exosome Diagnostics and Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Exosome Diagnostics and Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Exosome Diagnostics and Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Exosome Diagnostics and Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Exosome Diagnostics and Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Exosome Diagnostics and Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Exosome Diagnostics and Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Exosome Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Exosome Diagnostics and Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Exosome Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Exosome Diagnostics and Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Exosome Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Exosome Diagnostics and Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Exosome Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Exosome Diagnostics and Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Exosome Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Exosome Diagnostics and Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Aethlon Medical(US) Corporate Summary
Table 31. Aethlon Medical(US) Exosome Diagnostics and Therapeutics Product Offerings
Table 32. Aethlon Medical(US) Exosome Diagnostics and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Exosome Diagnostics(US) Corporate Summary
Table 34. Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Product Offerings
Table 35. Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. NanoSomix Inc.(US) Corporate Summary
Table 37. NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Product Offerings
Table 38. NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Thermo Fisher Scientific (US) Corporate Summary
Table 40. Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Product Offerings
Table 41. Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Malvern Instruments (UK) Corporate Summary
Table 43. Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Product Offerings
Table 44. Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. System Biosciences(US) Corporate Summary
Table 46. System Biosciences(US) Exosome Diagnostics and Therapeutics Product Offerings
Table 47. System Biosciences(US) Exosome Diagnostics and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. NX Pharmagen (US) Corporate Summary
Table 49. NX Pharmagen (US) Exosome Diagnostics and Therapeutics Product Offerings
Table 50. NX Pharmagen (US) Exosome Diagnostics and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Sistemic Inc(UK) Corporate Summary
Table 52. Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Product Offerings
Table 53. Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Capricor Therapeutics (US) Corporate Summary
Table 55. Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Product Offerings
Table 56. Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Exiqon A/S (Denmark) Corporate Summary
Table 58. Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Product Offerings
Table 59. Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Exosome Diagnostics and Therapeutics Segment by Type in 2021
Figure 2. Exosome Diagnostics and Therapeutics Segment by Application in 2021
Figure 3. Global Exosome Diagnostics and Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Exosome Diagnostics and Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Exosome Diagnostics and Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Exosome Diagnostics and Therapeutics Revenue in 2021
Figure 8. By Type - Global Exosome Diagnostics and Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Exosome Diagnostics and Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Exosome Diagnostics and Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Exosome Diagnostics and Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Exosome Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Exosome Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Exosome Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Exosome Diagnostics and Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Exosome Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Exosome Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Exosome Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Exosome Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Exosome Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Exosome Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Exosome Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Exosome Diagnostics and Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Exosome Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Exosome Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Exosome Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Exosome Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Exosome Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Exosome Diagnostics and Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Exosome Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Exosome Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Exosome Diagnostics and Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Exosome Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Exosome Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Exosome Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Exosome Diagnostics and Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Aethlon Medical(US) Exosome Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Exosome Diagnostics(US) Exosome Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. NanoSomix Inc.(US) Exosome Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Thermo Fisher Scientific (US) Exosome Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Malvern Instruments (UK) Exosome Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. System Biosciences(US) Exosome Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. NX Pharmagen (US) Exosome Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Sistemic Inc(UK) Exosome Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Capricor Therapeutics (US) Exosome Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Exiqon A/S (Denmark) Exosome Diagnostics and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)